Skip to content

Chuan Huang Fang control including cisplatin renal impairment caused by chemotherapy of clinical research

Chuan Huang Fang control including cisplatin renal impairment caused by chemotherapy of clinical research

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003764
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal impairment

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Need to use with cisplatin chemotherapy for malignant tumor patients (including lung cancer, gastric cancer, colorectal cancer); 2. belongs to the spleen and kidney deficiency syndrome differentiation of TCM, poison stasis mutual junction Primary symptoms: (1) languid lazy or shortness of breath; (2) nausea and vomiting; (3) was dark; (4) lumbar debility. Secondary symptoms: (1) often abdominal distension full; (2) less food, stay; (3) the skin a wrong; (4) thick greasy tongue coating; (5) tongue or dark purple bruises petechiae. In line with the primary symptom 4 and secondary symptoms item 1 ~ 2 can diagnose. 3. no contraindications to chemotherapy, agree to cisplatin chemotherapy based chemotherapy regimens and signed agreement; 4. no renal damage before chemotherapy 5. age 18 or more; 6. carr's score, Karnofsky 60 or more points; 7. is expected to survive period for 3 months or more; 8. no serious heart, liver, blood system diseases and other factors affecting drug evaluation.

Exclusion criteria

Exclusion criteria: 1. Older than 75 years old. 2. there is a clear heart, liver, or hematopoietic function damage, or psychiatric patients, pregnant women or nursing mothers. 3. are subjects to participate in other drugs. 4. not according to stipulations or information is not complete. 5. for treatment of drug allergy. 6. researchers say unfavorable to the participants.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score;Serum creatinine;Adverse events;

Countries

China

Contacts

Public ContactLingjia Tao

Shanghai Municipal Hospital of Traditional Chinese Medicine

tlingjia@163.com+86 13816601338

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026